help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gacad, M. A.
Right arrow Articles by Adams, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gacad, M. A.
Right arrow Articles by Adams, J. S.
The Journal of Clinical Endocrinology & Metabolism Vol. 83, No. 4 1264-1267
Copyright © 1998 by The Endocrine Society


Original Articles

Proteins in the Heat Shock-70 Family Specifically Bind 25-Hydroxyvitamin D3 and 17ß-Estradiol1

Mercedes A. Gacad and John S. Adams

Burns and Allen Research Institute and Division of Endocrinology and Metabolism, Cedars-Sinai Medical Center, University of California School of Medicine, Los Angeles, California 90048

Address all correspondence and requests for reprints to: John S. Adams, M.D., University of California School of Medicine, Division of Endocrinology and Metabolism, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Room B 131, Los Angeles, California 90048.

Abstract

Most New World primates evolved to express a form of compensated resistance to steroid hormones from the gonads and adrenal glands as well as to the hydroxylated vitamin D3 prohormone, 25-hydroxyvitamin D3 (25OHD3), and the vitamin D hormone 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] originating from the liver and kidney, respectively. We recently demonstrated that this form of resistance is associated with the overexpression of a novel member of the 70-kDa heat shock protein (hsp-70) molecular chaperone family, which we have termed the intracellular vitamin D binding protein (IDBP). In the current report we more closely examine the ligand-binding capability of purified IDBP and two other mammalian hsp-70 family members, heat-inducible (hsp-70) and constitutively expressed (hsc-70) hsp-70 proteins. Purified IDBP, hsp-70, and hsc-70 all bound 25OHD3 with relatively high affinity; the mean Kd for 25OHD3 ranged from 0.5–2.2 nmol/L (rank order: IDBP >= hsp-70 >= hsc-70). By Scatchard analysis, high affinity, specific binding of 1,25-(OH)2D3 was not reproducibly observed for any of the three members of the hsp-70 family. Unlike purified IDBP, hsc-70 and hsp-70 were also competent binders of the gonadal steroid 17ß-estradiol (mean Kd for 25OHD3, 2.5 and 6.6 nmol/L by hsc-70 and hsp-70, respectively), but not of two other gonadal hormones, progesterone and testosterone. These data suggest that IDBP is relatively specific for 25OHD3 and that additional hsp-70-like binding proteins are present in unpurified New World primate cell extracts that are specific for 1-hydroxylated vitamin D metabolites as well as other gonadal steroid hormones.

MOLECULAR chaperones of the 70-kDa heat shock protein (hsp-70) family are known to reside in all major compartments of eukaryotic cells (1). Although hsps undergo selective expression during conditions of metabolic stress (i.e. heat exposure), they are also expressed constitutively and participate in a variety of normal cellular processes, including protein folding, multimeric protein assembly, protein degradation, and the translocation of proteins across membranes (1, 2, 3, 4, 5). hsp-70 proteins are examples of energy-supplying chaperone proteins. The NH2-terminal portion of hsp-70 molecules (~44 kDa) binds ATP avidly, possesses ATP hydrolytic (adenosine triphosphatase) activity (6), and influences the binding and release of polypeptide substrates in the COOH-terminal (~27 kDa) part of the protein (7, 8).

We recently identified a novel member of the hsp-70 protein family, the intracellular vitamin D-binding protein (IDBP), and demonstrated that it interacts specifically with sterol and steroid ligands (9). IDBP is selectively overexpressed in New World primate (NWP) cells (10) and is associated with a vitamin D-, gonadal steroid-, and adrenal steroid-resistant state that is characteristic of most primates in the suborder Platyrrhini (11, 12, 13, 14, 15). Because of its extraordinarily high capacity for ligand (16), IDBP is proposed to act as an intracellular repository for hormones, disallowing access of these small lipid-soluble molecules to their cognate receptor proteins and thus contributing to the state of relative hormone resistance (9). Preliminary data (9) indicated that 25OHD3 binding may be shared by other hsp-70 proteins. The purpose of the current report is to confirm that observation and more clearly define the range of sterol/steroid hormone-binding capability of prototypical members of the hsp-70 family, including purified IDBP.

Materials and Methods

Compounds

[3H]25-hydroxyvitamin D3 ([3H]25OHD3; SA, 181 Ci/mmol) was purchased from Amersham (Arlington Heights, IL). Crystalline vitamin D3 metabolites were provided by Dr. Milan Uskokovic (Hoffmann-La Roche, Nutley, NJ). Steroids and buffer reagents were obtained from Sigma Chemical Co. (St. Louis, MO). Stress-inducible recombinant human hsp-70 and purified bovine constitutive hsp-70 (hsc-70) were obtained from StressGen (Victoria, Canada).

Cell culture

The B95–8 cell line (American Type Culture Collection, Rockville, MD) is a B lymphoblastoid cell line established by Epstein-Barr virus transformation of blood leukocytes from the vitamin D-resistant NWP Callithrix jacchus (common marmoset). The cell line was maintained in RPMI 1640 medium (Irvine Scientific, Santa Ana, CA) supplemented with 10% FCS (Gemini BioProducts, Calabasas, CA), 100 U/mL penicillin, 100 µg/mL streptomycin, and 4 mmol/L glutamine (all from Life Technologies, Grand Island, NY) within an atmosphere of 95% air-5% CO2.

IDBP extraction and purification

Extraction and purification of IDBP were accomplished as previously described by us (9). In summary, B95–8 cells were harvested, washed twice in ice-cold phosphate-buffered saline (20 mmol/L Na2HPO4 and 150 mmol/L NaCl, pH 7.2), resuspended in ETD buffer [1 mmol/L ethylenediamine tetraacetate, 10 mmol/L Tris-HCl (pH 7.4), and 5 mmol/L dithiothreitol] containing 1 mmol/L phenylmethylsulfonylfluoride and homogenized on ice in five 15-s bursts. Nuclei, with associated sterol/steroid receptor proteins, were pelleted at 4,000 x g for 30 min at 4 C. The supernatant was centrifuged at 100,000 x g for 1 h at 4 C and then either used in competitive ligand binding analyses or subjected to the following fast protein liquid chromatography (FPLC) sequence for purification of IDBP: 1) anion- exchange chromatography over bps-diethylamine cellulose (MetaChem Technologies, Torrance, CA) through an inclining NaCl gradient, 2) hydrophobic interaction chromatography over phenyl-Sepharose (Pharmacia Biotech, Alameda, CA) through a declining NaCl gradient, and 3) affinity chromatography over HTP-hydroxyapatite (Bio-Rad, Hercules, CA) through a declining Na2HPO4 gradient. The peak of specific [3H]25OHD3 binding was pooled, microconcentrated, and desalted through a Centricon concentrator with a nominal molecular mass cut-off of 30 kDa (Amicon, Beverly, MA).

Ligand binding analyses

Saturable, specific [3H]ligand binding was measured in crude B95–8 extract, in chromatographically purified protein preparations, and in solutions of hsp-70 and hsc-70 by competitive protein binding assay, and data were transformed by the method of Scatchard as previously described by us (16). Protein samples were adjusted to 0.5 mol/L with NaCl-containing ETD buffer (pH 8.0) and incubated overnight at 4 C with 4 nmol/L radioligand in the presence or absence of 1–100 nmol/L unlabeled competitive ligand. Protein-bound hormone was separated from unbound ligand with dextran-coated charcoal buffer.

Statistical analysis

When appropriate, experimental values for ligand binding under varying conditions were compared using Student’s t test for unpaired samples.

Results

hsp-70 and hsc-70 as vitamin D-binding proteins

Among the most well investigated members of the 70-kDa stress protein family in mammals are heat-inducible hsp-70 and constitutive hsc-70. Preparations of recombinant human hsp-70 and purified bovine hsc-70 were used as a source of potential binding protein. Five hundred nanograms per mL of either protein in 0.5 mol/L NaCl-ETD buffer rendered the highest yields of specific 25OHD3 binding and were optimal for 25OHD3 binding to IDBP in crude and purified cell extracts (9). The ability of increasing concentrations of 25OHD3 and 1,25-(OH)2D3 to displace 5 nmol/L [3H]25OHD3 from hsp-70 and hsc-70, respectively, is shown in the upper panels of Fig. 1Go. Maximal displacement of [3H]25OHD3 from hsp-70 was achieved with 100 nmol/L unlabeled 25OHD3. Scatchard transformation of the saturable binding data disclosed a mean Kd for 25OHD3 in the range of 2 nmol/L (Table 1Go). Similar observations were made with hsc-70 (Table 1Go and Fig. 1BGo). At least a 100-fold greater concentration of 1,25-(OH)2D3 was required to achieve the same 50% decrement in [3H]25OHD3 binding to hsp-70 and hsc-70 (Table 1Go and Fig. 1Go). The preference of hsp-70 and hsc-70 for 25OHD3 was confirmed using 5 nmol/L [3H]1,25-(OH)2D3 as the displaceable ligand (Fig. 1Go, C and D). A greater than 20% displacement of labeled hormone from either protein was not achieved until the competitive ligand concentration reached 100 nmol/L. Reminiscent of our observations in crude B95–8 cell extracts (9), internal alterations to the 25OHD metabolite side-chain (i.e. 25OHD2) and the presence of additional hydroxyl groups at the C-24 and C-26 positions did little to alter displaceable [3H]25OHD3 binding.



View larger version (28K):
[in this window]
[in a new window]
 
Figure 1. Competitive displacement of 5 nmol/L [3H]25OHD3 (A and B) and 5 nmol/L [3H]1,25-(OH)2D3 (C and D) from stress proteins hsp-70 (A and C) and hsc-70 (B and D) by increasing concentrations of radioinert 25OHD3 and 1,25-(OH)2D3. Each value in the upper panels (A and B) and the lower panels (C and D) is the mean of six and three assessments of specific binding, respectively. Asterisks denote a significant (P <= 0.02) reduction in total binding.

 

View this table:
[in this window]
[in a new window]
 
Table 1. Affinity of hsp-70-s for vitamin D sterol and gonadal steroid hormones using 5 nmol/L [3H]25OH-D3 as competitive ligand

 
Divergence of hormone-binding activity among hsp-70s

We previously showed (9) that crude NWP cell extracts were not specific for vitamin D metabolite binding; 17ß-estradiol, a steroid hormone of gonadal origin, was also shown to specifically bind in heterologous as well as homologous binding assays (17). As depicted in Fig. 2Go and Table 1Go, both hsp-70 and hsc-70 exhibited competitive displacement of [3H]25OHD3 when exposed to increasing concentrations of 17ß-estradiol. There was some apparent displacement of [3H]25OHD3 from hsp-70 and hsc-70 by high concentrations of testosterone and progesterone; however, 17ß-estradiol was at least 2 orders of magnitude more effective (Table 1Go and Fig. 2Go) and similar to 1,25-(OH)2D3 in hsp-70 and hsc-70 binding potential (Fig. 1Go, C and D). By contrast, estrone, the major circulating product of the adrenal androgen androstenedione, and its estrogen receptor-binding metabolites, 16{alpha}-hydroxyestrone and 2-hydroxyestrone (18), did not specifically bind to any of the hsps (data not shown).



View larger version (18K):
[in this window]
[in a new window]
 
Figure 2. Competitive displacement of 5 nmol/L [3H]25OHD3 from recombinant stress proteins hsp-70 (A) and hsc-70 (B) by increasing concentrations of radioinert gonadal steroid hormones. Each value is the mean of triplicate (testosterone and progesterone) or replicate (n = 6; 17ß-estradiol) assessments of specific binding. Asterisks denote a significant (P <= 0.02) reduction in total binding.

 
The ability to specifically bind 17ß-estradiol was not present in purified IDBP (Table 1Go), suggesting the presence of other binding proteins in crude NWP cell extracts (9) that share biochemical characteristics with IDBP, but interact specifically with other gonadal steroid hormones. To resolve this issue, we examined the displacement of 5 nmol/L [3H]25OHD3 by 100 nmol/L/25OHD3 and 17ß-estradiol after each chromatographic step used to purify IDBP (Fig. 3Go). [3H]25OHD3 displaceable binding by 25OHD3 and 17ß-estradiol copurified through extraction and diethylamine-anion exchange chromatography. However, there was preferential retention of 25OHD3 binding and loss of 17ß-estradiol binding to IDBP during the course of hydrophobic interaction chromatography. Further enrichment of 25OHD3 binding was observed after hydroxyapatite chromatography and was confirmed in homologous binding assays with either [3H]25OHD3 or [3H]17ß-estradiol and their respective radioinert competitive ligands (9). These results suggest that IDBP, unlike hsp-70 and hsc-70, is specific only for 25-hydroxylated vitamin D ligands.



View larger version (19K):
[in this window]
[in a new window]
 
Figure 3. The ratio of 25OHD3 to 17ß-estradiol (100 nmol/L) displaceable binding of 5 nmol/L [3H]25OHD3 from IDBP during the process of serial purification. extract, crude postnuclear supernatant of B95–8, NWP B lymphoblastoid cells; DEAE, postanion exchange FPLC over bps-diethylamine cellulose; HIC, posthydrophobic interaction FPLC over phenyl-Sepharose; HA, posthydroxyapatite FPLC (see Materials and Methods). Each value is the mean ± SD of triplicate assessments of the ratio of specific 25OHD3 to 17ß-estradiol binding. The asterisks indicate a significant increase (P <= 0.02) over the values obtained in crude B95–8 cell extracts.

 
Discussion

Primates inhabiting the South American subcontinent (NWPs) have evolved independently of primates inhabiting the African subcontinent [Old World primates (OWP)] (19). The only OWP over the last 30–50 million yr to successfully inhabit the New World is Homo sapiens, and that event occurred only in the last few thousand years (20). As a consequence of their independent evolution, platyrrhines (NWP) and catarrhines (OWP) have developed divergent phenotypes. One phenotypic difference is the presence of high circulating concentrations of sterol/steroid prohormones and hormones originating from the liver (25OHD3), kidney 1,25-(OH)2D3, adrenal cortex, and gonads in the presence of apparently normally functioning cellular receptor proteins for these hormones (10, 21). The proximal cause of hormone resistance remains uncertain, but may be due at least in part to the constitutive overexpression of two functionally distinct sets of intracellular proteins in NWP cells. One family of proteins exerts a dominant negative effect on hormone receptor-directed transcription (22, 23). A second set of proteins binds sterol/steroid hormones in the cytoplasmic and nuclear compartments (10); the first identified member of this second set, IDBP, effectively alters access of the vitamin D hormone to its cognate receptor (9).

We recently showed that IDBP was structurally related to hsp-70 proteins and that its preferred ligands were 25-hydroxylated vitamin D metabolites (9). This study also suggested that recombinant hsp-70 may be capable of specific 25OHD3 binding, albeit with lower affinity than purified IDBP. The purpose of the current experiments was to confirm this observation and extend it to another stress protein member, hsc-70, which is recognized as an important component of the cellular chaperone system in primate cells (24). Binding studies using radiolabeled 25OHD3 as displaceable ligand indicated that both recombinant hsp-70 and purified hsc-70 as well as purified IDBP were specific binding proteins for 25OHD3. The affinity of all three hsp proteins for 25OHD3 ranged from 0.5–2.2 nmol/L, with the rank order of binding potency being purified IDBP >= hsp-70 >= hsc-70.

An unexpected finding was the ability of hsp-70 and hsc-70, but not purified IDBP, to bind 17ß-estradiol in a competitive manner. These data suggest that hormone binding specificities may vary among the hsp-70 proteins, with some hsps being more versatile than others; hsp-70 and hsc-70 are apparently capable of incorporating a closed B ring steroid (17ß-estradiol) into the ligand-binding pocket, which also accepts a sterol with an open B ring (25OHD3), whereas purified IDBP cannot. This is supported by the fact that 25OHD3 and 17ß-estradiol specific binding activities were separated during IDBP purification and confirms our preliminary observations (9) that there is more than one hsp-70-related protein in NWP cell extracts capable of preferentially binding different gonadal steroids.

Before our recent observations (9), hsp-70s were not recognized as specific sterol/steroid ligand-binding proteins. It is possible that binding of small lipid-soluble ligands to hsp-70, like that of cyclosporine-like molecules binding to hsps in the immunophillin family (25), alters the protein ligand-binding potential of hsp-70-related molecules. It is also possible that hormone ligands somehow modify the cytoplasmic aporeceptor complexes for those steroid hormone receptors, including the estrogen, androgen, and glucocorticoid receptors, which are known to be associated with a number of heat shock-like proteins in the inactivated state (26); in this context, the hsp-70s may function as "approximator" proteins, bringing hormone in close proximity to receptor and promoting the hormone-receptor interaction. A potential caveat in this hypothesis is that neither hsp-70 nor hsp-90 is known to associate with the vitamin D receptor, and a hsp-70-related intracellular glucocorticoid-binding protein has not yet been discovered (9). Considering that IDBP appears to be more specific for 25OHD than for gonadal steroids, it is also possible that IDBP overexpression in NWP cells is essential for amplified translocation of substrate 25OHD3 to the inner mitochondrial membrane vitamin D 1- and 24-hydroxylase enzymes that are crucial for insuring that the demand for high circulating levels of the vitamin D hormone are met in NWP (27). In this regard, we have not yet fully characterized the NH2-terminal region of IDBP to determine whether it harbors a mitochondria-targeting sequence found in other hsp-70 proteins (1).

Acknowledgments

This work is dedicated to the memory of Dr. Bayard Catherwood (1948–1995), whose advice and encouragement were greatly appreciated. We are also grateful for the administrative assistance provided by Ms. R. Martinez.

Footnotes

1 This work was supported by NIH Grant AR-37399. Back

Received August 19, 1997.

Revised January 5, 1998.

Accepted January 8, 1998.

References

  1. Hartl FU. 1996 Molecular chaperones in cellular protein folding. Nature. 381:571–580.[CrossRef][Medline]
  2. Gething MJ, Sambrook J. 1992 Protein folding in the cell. Nature. 355:33–45.[CrossRef][Medline]
  3. Hendrick JP, Hartl FU. 1993 Molecular chaperone functions of heat-shock proteins. Annu Rev Biochem. 63:349–384.[CrossRef]
  4. Anfinsen CB. 1973 Principles that govern the folding of protein chains. Science. 8:223–230.
  5. Zhu X, Zhao X, Burkholder WF, et al. 1996 Structural analysis of substrate binding by the molecular chaperone DnaK. Science. 14:1606–1614.[CrossRef]
  6. Welch WJ. 1992 Mammalian stress response: cell physiology, structured/function of stress proteins, and implications for medicine and disease. Physiol Rev. 72:1063–1081.[Free Full Text]
  7. Palleros DR, Welch WJ, Fink AL. 1991 Interaction of hsp70 with unfolded proteins: effects of temperature and nucleotides on the kinetics of binding. Proc Natl Acad Sci USA. 88:5719–5723.[Abstract/Free Full Text]
  8. Palleros DR, Reid KL, Shi L, Welch WJ, Fink AL. 1997 ATP-induced protein-hsp70 complex dissociation requires K+ but not ATP hydrolysis. Nature. 365:664–666.[CrossRef]
  9. Gacad MA, Chen H, Arbelle JE, LeBon T, Adams JS. 1997 Functional characterization and purification of an intracellular vitamin D-binding protein in vitamin D-resistant New World primate cells. J Biol Chem. 272:8433–8440.[Abstract/Free Full Text]
  10. Gacad MA, Adams JS. 1991 Endogenous blockade of 1,25-dihydroxyvitamin D-receptor binding in New World primate cells. J Clin Invest. 87:996–1001.
  11. Adams JS, Gacad MA, Baker AJ, Gonzales B, Rude RK. 1985 Serum concentrations of 1,25-dihydroxyvitamin D3 in Platyrrhini and Catarrhini: a phylogenetic appraisal. Am J Primatol. 9:219–224.[CrossRef]
  12. Chrousos GPD, Brandon D, Renquist DM, et al. 1984 Uterine estrogen and progesterone receptors in an estrogen and progesterone-resistant primate. J Clin Endocrinol Metab. 58:516–520.[Abstract]
  13. Chrousos GPD, Loriaux L, Brandon DL, et al. 1984 Adaptation of the mineralcorticoid target tissues to the high circulating cortisol and progesterone plasma levels in the squirrel monkey. Endocrinology. 115:25–32.[Abstract]
  14. Lipsett MB, Chrousos GP, Tomita M, Brandon DD, Loriaux DL. 1985 The defective glucocorticoid receptor in man and non-human primates. Recent Prog Horm Res. 42:199–246.
  15. Brandon DD, Markwick AJ, Chrousos GP, Loriaux DL. 1989 Glucocorticoid resistance in humans and nonhuman primates. Cancer Res. 49:2203–2213.
  16. Gacad MA, Adams JS. 1993 Identification of a competitive binding component in vitamin D-resistant New World primate cells with a low affinity but high capacity for 1,25-dihydroxyvitamin D3. J Bone Miner Res. 8:27–35.[Medline]
  17. Gacad MA, Adams JS. 1992 Specificity of steroid binding in New World primate B95–8 cells with a vitamin D-resistant phenotype. Endocrinology. 132:2581–2587.
  18. Lim SK, Won YJ, Kwon SH, et al. 1997 Altered hydroxylation of estrogen in patients with postmenopausal osteopenia. J Clin Endocrinol Metab. 82:1001–1006.[Abstract/Free Full Text]
  19. Philbeam D. 1984 The descent of the hominoids and hominids. Sci Am. 250:84–96.[Medline]
  20. Milton K. 1993 Diet and primate evolution. Sci Am. 269:86–93.
  21. Brandon DD, Markwick AJ, Flores M, Dixon K, Albertson BD, Loriaux DL. 1991 Genetic variation of the glucocorticoid receptor from a steroid-resistant primate. Mol Endocrinol. 7:89–96.
  22. Arbelle JE, Chen H, Gacad MA, Allegretto EA, Pike JW, Adams JS. 1996 Inhibition of vitamin D receptor-retinoid X receptor-vitamin D response element complex formaion by nuclear extracts of vitamin D-resistant New World primate cells. Endocrinology. 137:786–789.[Abstract]
  23. Chen H, Arbelle JE, Gacad MA, Allegretto EA, Adams JS. 1997 Vitamin D and gonadal steroid-resistant New World primate cells express an intracellular protein which competes with the estrogen receptor for binding to the estrogen response element. J Clin Invest. 99:669–675.[Medline]
  24. Minowada G. 1995 Clinical implications of the stress response. J Clin Invest. 95:3–12.
  25. Clardy J. 1995 The chemisty of signal transduction. Proc Natl Acad Sci USA. 92:56–61.[Abstract/Free Full Text]
  26. Bohen SP, Kralli A, Yamamoto KR. 1995 Hold ’em and fold ’em: chaperones and signal transduction. Science. 268:1303–1304.[Free Full Text]
  27. Gacad MA, Adams JS. 1992 Influence of ultraviolet B radiation on vitamin D3 metabolism in vitamin D3-resistant New World primates. Am J Primatol. 28:263–270.



This article has been cited by other articles:


Home page
J Mol EndocrinolHome page
R F Chun, M Gacad, L Nguyen, M Hewison, and J S Adams
Co-chaperone potentiation of vitamin D receptor-mediated transactivation: a role for Bcl2-associated athanogene-1 as an intracellular-binding protein for 1,25-dihydroxyvitamin D3
J. Mol. Endocrinol., August 1, 2007; 39(2): 81 - 89.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. Chun, M. A. Gacad, M. Hewison, and J. S. Adams
Adenosine 5'-Triphosphate-Dependent Vitamin D Sterol Binding to Heat Shock Protein-70 Chaperones
Endocrinology, December 1, 2005; 146(12): 5540 - 5544.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. S. Dusso, A. J. Brown, and E. Slatopolsky
Vitamin D
Am J Physiol Renal Physiol, July 1, 2005; 289(1): F8 - F28.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Chen, M. Hewison, B. Hu, M. Sharma, Z. Sun, and J. S. Adams
An Hsp27-related, Dominant-negative-acting Intracellular Estradiol-binding Protein
J. Biol. Chem., July 16, 2004; 279(29): 29944 - 29951.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. A Babiker, L. J De Windt, M. van Eickels, C. Grohe, R. Meyer, and P. A Doevendans
Estrogenic hormone action in the heart: regulatory network and function
Cardiovasc Res, February 15, 2002; 53(3): 709 - 719.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Wu, S. Ren, H. Chen, R. F. Chun, M. A. Gacad, and J. S. Adams
Intracellular Vitamin D Binding Proteins: Novel Facilitators of Vitamin D-Directed Transactivation
Mol. Endocrinol., September 1, 2000; 14(9): 1387 - 1397.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
H. Chen, B. Hu, M. A. Gacad, and J. S. Adams
Cloning and Expression of a Novel Dominant-Negative-acting Estrogen Response Element-binding Protein in the Heterogeneous Nuclear Ribonucleoprotein Family
J. Biol. Chem., November 20, 1998; 273(47): 31352 - 31357.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gacad, M. A.
Right arrow Articles by Adams, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gacad, M. A.
Right arrow Articles by Adams, J. S.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals